Should We Discontinue Medications in Older Patients With Multiple Sclerosis?

We’re fortunate today to have John Corboy as our guest. He started
the first one of these trials, and it has just recently been completed.
He'll talk to us about that. Corboy is a professor of neurology,
executive vice chair of neurology at the University of Colorado School
of Medicine, and medical director of the Rocky Mountain MS Center.